SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,218,624.4003947. The last known price of Ethereum is 1,739.90377069 USD and is down -9.84 over the last 24 hours. It is currently trading on 14359 active market(s) with $18,820,901,710.98 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Ethereum is caught in a broad crypto selloff alongside Bitcoin, with traders pointing to forced liquidations and wider risk-off pressure. The community is split between calling the drop capitulation and buying the dip, and warning that weak demand could lead to further losses.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 0.92173784 USD and is down -8.73 over the last 24 hours. It is currently trading on 1896 active market(s) with $4,059,642,828.82 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

A broad crypto selloff, with Bitcoin weakness weighing on XRP, dominates discussion. Traders are divided between treating the steep decline as a buying opportunity and fearing further losses, with bearish posts also questioning XRPs supply and utility.

Dogecoin (DOGE) is a cryptocurrency . Users are able to generate DOGE through the process of mining. Dogecoin has a current supply of 156,752,062,860.16806072. The last known price of Dogecoin is 0.05689686 USD and is down -11.89 over the last 24 hours. It is currently trading on 1545 active market(s) with $1,128,721,930.78 traded over the last 24 hours. More information can be found at http://dogecoin.com/.

Dogecoin

Dogecoin is drawing attention amid a sharp, extended selloff that traders link to weakness across the broader crypto market, with concern about fresh lows and limited buying interest. The community is split between holders viewing the decline as a buying opportunity and skeptics expecting further losses and questioning the coins utility.

Solana (SOL) is a cryptocurrency launched in 2020. Solana has a current supply of 637,554,569.48929238 with 591,573,607.37721086 in circulation. The last known price of Solana is 69.50906472 USD and is down -10.60 over the last 24 hours. It is currently trading on 1189 active market(s) with $4,775,978,662.51 traded over the last 24 hours. More information can be found at https://solana.com.

Solana

Solana is under pressure amid a broad crypto selloff, with traders focused on its sharp decline and whether further losses or a bottom may be ahead. Bearish posts warn of a continuing downtrend, while others view the weakness as a buying opportunity and are accumulating or staking SOL.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Bitcoins sharp decline is weighing on Strategy as traders treat it as a leveraged Bitcoin proxy; discussion also points to its announced removal from MSCI indices as a potential source of forced selling. Sentiment is largely bearish, with concerns about dilution and financing alongside some dip-buying and hopes for a Bitcoin rebound.

Avalanche (AVAX) is a cryptocurrency launched in 2020. Avalanche has a current supply of 471,438,169.1160568 with 446,436,169.1160568 in circulation. The last known price of Avalanche is 6.99518175 USD and is down -15.00 over the last 24 hours. It is currently trading on 1135 active market(s) with $402,139,637.32 traded over the last 24 hours. More information can be found at https://avax.network/.

Avalanche

A sharp AVAX selloff amid Bitcoin weakness and a broader altcoin rout is dominating discussion. Traders are split between viewing the drop as a buying opportunity and warning of further losses, while many complain that rebounds keep fading.

Litecoin (LTC) is a cryptocurrency . Users are able to generate LTC through the process of mining. Litecoin has a current supply of 84,000,000 with 77,830,936.34364598 in circulation. The last known price of Litecoin is 43.58319249 USD and is down -11.87 over the last 24 hours. It is currently trading on 1567 active market(s) with $330,181,316.06 traded over the last 24 hours. More information can be found at https://litecoin.org/.

Litecoin

Litecoin is drawing attention for a sharp selloff amid broader crypto weakness, with traders saying it has underperformed and lost support. Bearish posts warn of further downside, while others view the decline as a buying opportunity and are accumulating.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

Analyst downgrades and price-target cuts following UiPaths investor-day presentations have fueled a sharp selloff, with traders debating whether concerns about slowing growth and AI monetization outweigh the companys agentic-automation opportunity. Bulls view the decline as a valuation opportunity, while bears question whether new products and partnerships can translate into stronger business growth.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingos Q3 results, accelerating user growth and higher full-year guidance have driven a sharp rally. Bulls point to stronger engagement and the possibility of short covering, while skeptics focus on the EPS miss and lingering concerns about monetization, valuation and AI competition.

Quant (QNT) is a cryptocurrency and operates on the Ethereum platform. Quant has a current supply of 14,881,364 with 12,072,738 in circulation. The last known price of Quant is 141.66985362 USD and is down -11.02 over the last 24 hours. It is currently trading on 416 active market(s) with $104,643,915.79 traded over the last 24 hours. More information can be found at https://quant.network/.

Quant

QNT is drawing attention amid a sharp pullback and broader crypto-market weakness, with traders debating whether selling has further to run or the decline is a chance to accumulate. Long-term bulls point to Quants anticipated role in banking tokenization and a planned Clearing House network launch, while skeptics question how soon that thesis will translate into token demand.

statis crypto Watchlist

Bitcoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Medpace (MEDP) Stock Outpacing Its Medical Peers This Year?

Here is how Medpace (MEDP) and Atea Pharmaceuticals, Inc. (AVIR) have performed compared to their sector so far this year.

Atea Pharmaceuticals Q3 2026 Earnings Call Transcript

Atea Pharmaceuticals (NASDAQ:AVIR) reported third-quarter financial results on Monday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzingaread more...

Atea Pharmaceuticals Says Hepatitis C Drug Matches Gilead's in Pivotal Trial

Atea Pharmaceuticals announced positive Phase 3 C-BEYOND trial results for its oral hepatitis C combination therapy vs. Gilead's therapy.read more...

Atea Pharmaceuticals (AVIR) Upgraded to Buy: Here's What You Should Know

Atea Pharmaceuticals (AVIR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Are Medical Stocks Lagging  Atea Pharmaceuticals (AVIR) This Year?

Here is how Atea Pharmaceuticals, Inc. (AVIR) and Design Therapeutics, Inc. (DSGN) have performed compared to their sector so far this year.

Down 25% in 4 Weeks, Here's Why Atea Pharmaceuticals (AVIR) Looks Ripe for a Turnaround 

Atea Pharmaceuticals (AVIR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Atea Pharmaceuticals Q1 2026 Earnings Call: Complete Transcript

Atea Pharmaceuticals (AVIR) Expected to Announce Quarterly Earnings on Tuesday

Atea Pharmaceuticals (NASDAQ:AVIR) will be releasing its Q1 2026 earnings after the market closes on Tuesday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-12-atea-pharmaceuticals-inc-stock...

Atea Pharmaceuticals (NASDAQ:AVIR) Stock Price Up 1.6% - Still a Buy?

Atea Pharmaceuticals (NASDAQ:AVIR) Shares Up 1.6% - Time to Buy...

Atea Pharmaceuticals (NASDAQ:AVIR) Stock Price Up 5.9% - Here's Why

Atea Pharmaceuticals (NASDAQ:AVIR) Shares Up 5.9% - Time to Buy...

• Reported GAAP EPS of -$0.40 up 24.53% YoY
• Atea Pharmaceuticals believes existing resources, including $65M borrowed, will fund planned operations into mid-2028; based on current plans, it does not anticipate product sales revenue for the foreseeable future.

Atea Pharmaceuticals has no product revenue and continues operating losses; BEM/RZR still requires successful C-FORWARD completion, while ruzasvir relies on a sole Chinese API supplier and debt is secured by substantially all assets.

Atea Pharmaceuticals reported C-BEYOND non-inferiority to SOF/VEL with an eight-week regimen for non-cirrhotic patients; AT-587 entered Phase 1, and funding is projected to support operations into mid-2028.

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.

Atea Pharmaceuticals Inc

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

AVIR News